Summary of Key Points Core Viewpoint - The Hong Kong stock market saw significant net inflows from northbound trading, with a total net buy of 94.85 billion HKD on August 6, 2023, indicating strong investor interest in certain stocks, particularly Tencent, Alibaba, and SMIC, while Xiaomi faced notable net selling. Group 1: Northbound Trading Activity - Northbound trading recorded a net buy of 94.85 billion HKD, with 44.69 billion HKD from Shanghai Stock Connect and 50.16 billion HKD from Shenzhen Stock Connect [1] - The most bought stocks included Tencent (00700), Alibaba-W (09988), and SMIC (00981), while Xiaomi Group-W (01810) was the most sold stock [1] Group 2: Individual Stock Performance - Tencent Holdings (00700) had a net buy of 26.36 billion HKD, with total buy and sell amounts of 45.54 billion HKD and 19.18 billion HKD respectively, resulting in a net inflow of 7.18 billion HKD [2] - Alibaba-W (09988) saw a net buy of 19.21 billion HKD, with total transactions of 31.64 billion HKD, leading to a net inflow of 6.78 billion HKD [2] - SMIC (00981) experienced a net buy of 13.47 billion HKD, with total buy and sell amounts of 23.30 billion HKD and 9.83 billion HKD respectively, resulting in a net inflow of 3.64 billion HKD [2] Group 3: Market News and Developments - Tencent's net buy of 15.17 billion HKD was supported by positive news regarding its mobile game "无畏契约," which has over 50 million pre-registrations and is expected to generate annual revenue of 5 to 6 billion HKD [5] - Alibaba's net buy of 8.76 billion HKD was influenced by the launch of a new membership system that integrates various services, marking a strategic shift towards a comprehensive consumer platform [5] - SMIC is expected to report a decline in quarterly revenue for the first time in two years, with a projected decrease of 4% to 6% [6]

Core Viewpoint - The Hong Kong stock market saw significant net buying from Northbound capital, totaling HKD 94.85 billion on August 6, with Tencent, Alibaba, and SMIC being the most favored stocks, while Xiaomi faced the highest net selling pressure [1][2]. Group 1: Northbound Capital Activity - Northbound capital recorded a net buying of HKD 94.85 billion, with HKD 44.69 billion from the Shanghai Stock Connect and HKD 50.16 billion from the Shenzhen Stock Connect [1]. - The top net buying stocks included Tencent (00700), Alibaba-W (09988), and SMIC (00981) [1]. - Xiaomi Group-W (01810) experienced the highest net selling, amounting to HKD 2.29 billion [6]. Group 2: Individual Stock Performance - Tencent Holdings (00700) had a net inflow of HKD 7.18 billion, driven by positive market sentiment regarding its upcoming mobile game "无畏契约," which has over 50 million pre-registrations [4][5]. - Alibaba-W (09988) saw a net inflow of HKD 6.78 billion, following the launch of a new membership system that integrates various services across its platforms [5]. - SMIC (00981) recorded a net inflow of HKD 3.64 billion, with expectations of a revenue decline in Q2 but positioned as a core beneficiary of high-end replacements [5][6]. - Crystal Technology (02228) gained a net inflow of HKD 5.32 billion due to a significant partnership with DoveTree for drug development [6]. - Ideal Auto-W (02015) had a net inflow of HKD 1.58 billion after announcing adjustments to its vehicle configurations based on user feedback [6].

投资要点 腾讯控股今日涨1.70%，短线资金持续流入，前5日加仓416万股。 阿里巴巴-W今日涨0.60%，短线资金以流入为主，前5日加仓1654万股。 中芯国际今日涨3.14%，短线资金流入趋缓，前5日加仓784万股。 晶泰控股今日涨12.42%，短线资金加速流入，前5日加仓2319万股。 小米集团-W今日跌0.55%，短线资金以流入为主，前5日加仓6177万股。 泡泡玛特今日涨7.87%，短线资金延续流出趋势，前5日减持326万股。 注：由于港交所T+2结算，实际为向前递延两个交易日的前5日数据。 | | | 1322.93 智通财经8月6日讯（编辑 冯轶）据Wind数据显示，南向资金今日成交约1259.74亿港元，较前一日微幅下滑；约为今日恒指成交总额的58.53%，占比近两日 连续抬高。 全天恒指横盘震荡，南向资金净流入约94.85亿港元，其中沪港股通净流入约44.69亿港元，深港股通净流入约50.16亿港元。 个股方面，交易所数据显示，今日南向资金 大幅净买入：腾讯控股(0700.HK)15.18亿港元；阿里巴巴-W(09988.HK)8.76亿港元；中芯国际(00981.HK)6.12亿港元；晶泰 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 康方生物科技（開曼）有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09926 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.00001 USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 5,000,000,000 | USD | | 0.00001 USD | | 50,000 | 本月底法定/註冊股本總額： USD 50,0 ...

8月6日消息，南向资金今日成交1259.74亿港元，净流入约94.85亿港元。其中沪港股通净流入约44.69亿 港元，深港股通净流入约50.16亿港元 交易所数据显示，8月6日南向资金动向： 大幅净买入：腾讯控股(00700.HK)15.18亿港元、阿里巴巴-W(09988.HK)8.76亿港元、中芯国际 (00981.HK)6.12亿港元、晶泰控股(02228.HK)5.33亿港元、康方生物(09926.HK)1.38亿港元、理想汽车- W(02015.HK)1.19亿港元。 晶泰控股今日涨12.42%，沪港股通净买入4.75亿港元，深港股通净买入5750.15万港元。 康方生物今日涨5.03%，深港股通净买入1.38亿港元。 理想汽车W今日跌5.35%，沪港股通净买入1.58亿港元，深港股通净卖出3918.97万港元。 小米集团W今日跌0.55%，沪港股通净卖出8501.64万港元，深港股通净卖出14410.94万港元。 泡泡玛特今日涨7.87%，沪港股通净卖出31306.92万港元，深港股通净买入8996.36万港元。 美团W今日跌1.46%，沪港股通净买入2.37亿港元，深港股通净卖出38412.99 ...

Summary of Key Points Core Viewpoint - The Hong Kong stock market experienced significant net inflows from northbound trading, with a total net buy of 94.85 billion HKD on August 6, 2023, indicating strong investor interest in certain stocks, particularly Tencent, Alibaba, and SMIC, while Xiaomi faced notable net selling [1][4]. Group 1: Northbound Trading Activity - Northbound trading through Stock Connect saw a net buy of 44.69 billion HKD from Shanghai and 50.16 billion HKD from Shenzhen [1]. - The most bought stocks included Tencent (00700), Alibaba-W (09988), and SMIC (00981) [1]. - Xiaomi Group-W (01810) was the most sold stock, with a net sell of 2.29 billion HKD [6]. Group 2: Individual Stock Performance - Tencent Holdings (00700) had a net buy of 26.36 billion HKD, with total trading volume of 45.54 billion HKD, reflecting a net inflow of 7.18 billion HKD [2]. - Alibaba-W (09988) saw a net buy of 19.21 billion HKD, with total trading volume of 31.64 billion HKD, resulting in a net inflow of 6.78 billion HKD [2]. - SMIC (00981) recorded a net buy of 13.47 billion HKD, with a total trading volume of 23.30 billion HKD, leading to a net inflow of 3.64 billion HKD [2]. Group 3: Company-Specific News - Tencent's new mobile game "无畏契约" is anticipated to generate annual revenue of 5 to 6 billion CNY, with over 50 million pre-registrations [4]. - Alibaba launched a new membership system integrating various services, marking a strategic shift towards a comprehensive consumer platform [5]. - SMIC is expected to report a quarterly revenue decline for the first time in two years, with a guidance range of 4% to 6% [5]. - Crystal Technology (02228) secured a record order of approximately 470 billion HKD (59.9 billion USD) for drug development collaboration [6].

Core Viewpoint - The article discusses the performance of the Chinese stock market in July, highlighting that A-shares outperformed Hong Kong stocks due to various factors, including government policies and market dynamics [4][5]. Group 1: Market Performance - In July, major Chinese stock indices such as the Wind All A, CSI 300, and Hang Seng Index saw increases of +4.75%, +3.54%, and +2.91% respectively, indicating a stronger performance of A-shares compared to Hong Kong stocks [4]. - The article notes that small-cap stocks in A-shares showed stronger performance than large-cap stocks during this period [4]. Group 2: Factors Influencing A-share Performance - The central government's "anti-involution" supply-side reform measures announced on July 1 are believed to have positively impacted investor sentiment, particularly in cyclical industries that are expected to recover [5]. - The high market activity and significant gains in individual stocks have improved risk appetite among investors, leading to increased market participation [5]. Group 3: Bull Market Dynamics - The article explores how bull markets form, emphasizing that economic improvement is not a prerequisite for a bull market; rather, market valuations and investor sentiment play crucial roles [8][14]. - Historical data shows that the Producer Price Index (PPI) can reflect macroeconomic conditions, and past bull markets have occurred even during periods of negative PPI growth [9]. Group 4: Investor Behavior in Bull Markets - The article identifies common reasons why many investors fail to profit during bull markets, including selling stocks during market lows out of fear and missing out on subsequent gains [15][16]. - It highlights the psychological barriers and decision-making challenges investors face, such as fear of missing out and the difficulty in identifying the right stocks to buy [17][18]. Group 5: Current Market Strategy - The article suggests that the current market may be characterized as a structural bull market, with potential for cyclical recovery in certain sectors due to government policies [21]. - It advises investors to avoid perfectionism in their investment strategies and to focus on achieving reasonable returns rather than waiting for the perfect entry point [22].

截至13:33，恒生港股通创新药指数（HSSCID）跌1.29%，权重股中，晶泰控股涨8.2%，同源康医药-B 涨1.6%，康方生物涨1.4%，锦欣生殖涨0.3%，欧康维视生物-B涨0.3%，和黄医药跌0.4%，四环医药跌 0.7%，远大医药涨0.3%，康哲药业涨1.1%，石药集团跌0.5%。 今年前7个月，江苏获批上市的创新药达14个，已超去年全年的13个。全国共有49个创新药获批上市。 中金公司指出，看好创新药长期产业发展趋势。国内工程师红利、丰富临床资源和支持性政策多边加持 下，国产创新药已逐渐从跟随时代走向FIC/BIC创新。经历几年耕耘，国内品种商业化放量，并有望受 益于支付端政策改革，创新药企盈利能力提升；在研管线数据优异，大额BD持续达成。进入2.0时代的 创新药产业已经逐步完成质的提升。 相关产品： 易方达恒生港股通创新药联接A(024328) 易方达恒生港股通创新药联接C(024329) ...

截至2025年8月6日 10:32，中证香港创新药指数(931787)下跌1.33%。成分股方面涨跌互现，康希诺生物 (06185)领涨12.57%，晶泰控股(02228)上涨6.67%，远大医药(00512)上涨2.83%；君实生物(01877)领跌， 绿叶制药(02186)、三生制药(01530)跟跌。港股创新药ETF(513120)红盘蓄势。 流动性方面，港股创新药ETF盘中换手26.06%，成交43.40亿元，市场交投活跃。拉长时间看，截至8月 5日，港股创新药ETF近1周日均成交121.72亿元。 港股创新药ETF(513120)，（联接A:019670，联接C:019671）：紧密跟踪中证香港创新药指数，投资港 股创新药产业。值得注意的是，港股创新药ETF(513120)支持T+0交易，这意味着投资者可以在交易日 内进行多次买卖，极大地提高了资金的使用效率和流动性。 港股创新药ETF紧密跟踪中证香港创新药指数，根据申万二级行业分布，中证香港创新药指数生物制品 +化学制药权重占比达92.5%，这也是当下ETF跟踪的指数中，较为"纯血"的创新药行业指数之一。 数据显示，截至2025年7月31日，中证香 ...

Core Viewpoint - The Hong Kong stock market opened slightly lower on August 6, with innovative drugs continuing to be active, particularly the high-profile Hong Kong Stock Connect innovative drug ETF (520880), which rose by 1.37% in early trading, aiming for a third consecutive daily gain [1]. Group 1: Company Developments - On August 5, Crystal Tech Holdings announced a pipeline collaboration agreement with DoveTree, with a total order scale of approximately HKD 470 billion (USD 59.9 billion), marking one of the largest business development transactions in China's AI pharmaceutical sector by 2025 [2][3]. - Crystal Tech Holdings has received an initial payment of USD 51 million under the final agreement and is entitled to further payments of USD 49 million (to be paid within 180 days), as well as potential milestone payments of up to USD 5.89 billion based on regulatory and commercial achievements, along with royalties based on annual net sales [3]. Group 2: Industry Trends - The domestic innovative drug sector is entering a period of technological breakthroughs, with the National Medical Products Administration reporting that 43 innovative drugs were approved in the first half of the year, a year-on-year increase of 59%, nearing the total of 48 for the entire year of 2024 [3]. - According to China International Capital Corporation, the long-term development trend of the innovative drug industry is promising, supported by domestic engineer advantages, abundant clinical resources, and favorable policies [3]. - The innovative drug sector is expected to benefit from policy reforms in payment systems, enhancing the profitability of innovative drug companies, with many stocks in the sector showing strength as they enter the 2.0 era [3]. Group 3: Market Performance - The Hong Kong Stock Connect innovative drug ETF (520880) passively tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index, which focuses on the innovative drug industry chain, primarily consisting of innovative drug research and development companies [4]. - As of July 31, the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index has risen by 101.58% year-to-date, significantly outperforming the Hang Seng Index (23.50%) and the Hang Seng Tech Index (22.05%) by 78.08 and 79.53 percentage points, respectively [6][7].